PNG’s HIV epidemic is predominately driven through heterosexual transmission. That said, other modes of transmission observed include vertical transmission and male-to-male sex. A few sporadic cases of HIV have been diagnosed whereby the mode of transmission has been reported as tattooing and injecting drug use. The data on those who have been diagnosed with HIV as a result of injecting drug use is sparse. It is unclear for example if such people are indeed ethnic Papua New Guineans or if in the case of expatriates the virus was contracted via injecting drug use practices outside of PNG. There have been other anecdotal, but unverified, reports of injecting drug use occurring in PNG and concern has been raised over this being a possible route of transmission that with the potential of contributing to the epidemic. Download this document.
Emerging HIV Risk in Papua New Guinea. Kelly A, Mathers B, Kawage T and Vallely A. (2012)
China Data Sheets. HIV and AIDS Data Hub for Asia Pacific (2013)
China Data Sheets have been updated.
Bangladesh Data Sheets. HIV and AIDS Data Hub for Asia Pacific (2013)
Bangladesh Data Sheets have been updated.
Costs and Cost-effectiveness of HIV Prevention and Impact Mitigation Interventions in Cambodia. National AIDS Authority, Cambodia. (2012)
This report is aimed at assisting in building the case for the need for significant improvements across prevention and impact mitigation interventions leading to a “value for money”, cost-effective national response. Each of the main sections in this report are focused on key affected populations—Entertainment Workers (EW) who sell sex, men who have sex with men (MSM) and transgender people (TG) and injecting drug users (IDUs). Each population section goes through the assumptions and results of both the costing and cost-effectiveness analyses for each group. Download this document.
Annual Report 2011. Ministry of Health, Cambodia. (2012)
This report describes the achievement of program implementation on HIV/AIDS and STI prevention, care, support and treatment during the year 2011. The report is intended to aggregate data and information collected from all OI/ART, VCCT, Family Health Clinics, HBC, and PMTCT sites from the whole country to be represented as the National Comprehensive Report for the health sector response to HIV/AIDS and STI in Cambodia. The following sections reported the main three program areas implemented for this year that are including: A) General Report related to Programme management and implementation; B) Results from health service deliveries; C) Financial Report for descript the financial disbursements against the yearly budget plan; D) Procurement of OI/ARV Drugs, E) Challenges etc. Download this document.
Social Return on Investment Doing More with Less: Evidence based Operational Research on the KHANA Integrated Care and Prevention Project in Cambodia. Phnom Penh, KHANA. Tong L, H Sopheab, Tuot S. (2012)
Cambodia has been praised for its success in slowing its HIV epidemic: by 2010 HIV prevalence had fallen to 0.8% from a peak of over 2% a decade before . Outstanding national leadership and commitment was recognised through a Millennium Development Goal Award in 2010, when Cambodia reached its universal access target for antiretroviral treatment. The focus now needs to be on ensuring the most effective use of resources whilst maintaining a strong impact at the national level.
KHANA is the largest national non-governmental organisation (NGO) providing HIV prevention, care and support services in Cambodia. Initially established in 1996 as a project of the International HIV/AIDS Alliance, KHANA became an NGO in its own right in 1997. In 2008 it went through the International HIV/AIDS Alliance accreditation process, and was the first Alliance partner to receive full endorsement as an accredited member. Download this document.
Harm Reduction Model of Comprehensive Drop in Center for People who Use Drugs. Sovannary T and Sopheab H. (2012)
An operational research was conducted to assess the innovative model of the Center, identify barriers, challenges and lessons learned during program implementation. This report details on the findings of the research. Both quantitative and qualitative methods were employed in the operational research. The quantitative data was collected from KMDC’s monitoring and evaluation (M & E) database and reports. The qualitative data was collected from interviews and focused group discussions (FGD) with more than 30 respondents, ranging from key informants to PWUD/PWID, in an effort to obtain a comprehensive picture of the KMDC. Desk reviews and consultative meetings were also used to complement this study. Download this document.
Untangling the Web of Antiretroviral Price Reductions - 15th Edition July 2012. Medecins Sans Frontieres. (2012)
Now is a critical time to ensure widest possible access to ART: a landmark scientific breakthrough in 2011 showed that treatment with antiretroviral medicines (ARVs) not only saves lives, but can also stop HIV from being transmitted by up to 96%.4 In response to this evidence, in 2012 the World Health Organization (WHO) issued guidance supporting immediate treatment – regardless of a person’s immune system’s status or CD4 count – for HIV-positive people who have HIV-negative partners, in order to help prevent transmission of the virus.5 At the same time, guidance was also issued suggesting the possibility of offering full antiretroviral therapy for life to all pregnant women living with HIV for prevention of mother-to-child transmission of the virus (PMTCT). Download this document.
- Meeting Report - Consultation on The Memorandum of Understanding to Reduce HIV Vulnerability Associated with Population Movement. UNDP, Joint United Nations Initiative on Mobility and HIV in South East Asia, and ADB. (2012)
- Stop Imprisonment, Time for Rehabilitation. Open Society Institute (2012)
- Investing In Communities Achieves Results: Findings from an Evaluation of Community Responses to HIV and AIDS. Rodriguez-García R, Bonnel R, Wilson D, and N’Jie ND. (2013)
- Learn about Your Rights - Training Manual on HIV and the Law. Hien BT, Thu LTH, Nga PTT, and et al. (2012)
Page 4 of 29